Abbisko Therapeutics

[On Demand]
Search General Info
Search Education
Search Partnering Companies
A clinical stage oncology start-up with a small molecule pipeline of 12 programs for FIC/BIC (7 in target therapy and 5 in I/O therapy) with 4 of which in clinical phase 1 and 2 from across the US and China, etc.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
China
Year Founded:
2016
Main Therapeutic Focus:
Lead Product in Development:
two FGFR targeted and two I/O therapy (small molecule)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
12
Speaker
photo
CBO
Abbisko Therapeutics Co. Ltd.